{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:16:15Z","timestamp":1793322975901,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ymgme.2014.07.022","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T18:42:18Z","timestamp":1407177738000},"page":"213-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients"],"prefix":"10.1016","volume":"113","author":[{"given":"Annalisa","family":"Sechi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Deroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ciana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Concolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Linari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Perria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bembi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.07.022_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2641","article-title":"Glucosylceramid lipidoses: Gaucher disease","author":"Beutler","year":"1995"},{"key":"10.1016\/j.ymgme.2014.07.022_bb0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.ymgme.2014.07.022_bb0015","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.43.10.1993","article-title":"Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease","volume":"43","author":"Patterson","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2014.07.022_bb0020","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2014.07.022_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.ymgme.2014.07.022_bb0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2014.07.022_bb0040","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10545-007-0577-z","article-title":"Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases","volume":"30","author":"Davies","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2014.07.022_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2007.12.023","article-title":"Cognitive outcome in treated patients with chronic neuronopathic Gaucher disease","volume":"153","author":"Goker-Alpan","year":"2008","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2014.07.022_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.braindev.2010.02.005","article-title":"A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients","volume":"33","author":"Kraoua","year":"2011","journal-title":"Brain Dev."},{"issue":"2","key":"10.1016\/j.ymgme.2014.07.022_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bcmd.2012.09.008","article-title":"Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy","volume":"50","author":"Elstein","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2014.07.022_bb0060","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"4 Suppl. 5","key":"10.1016\/j.ymgme.2014.07.022_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"issue":"6","key":"10.1016\/j.ymgme.2014.07.022_bb0070","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions","volume":"43","author":"Lewiecki","year":"2008","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ymgme.2014.07.022_bb0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2014.07.022_bb0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08035250500423804","article-title":"Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease","volume":"95","author":"Erikson","year":"2006","journal-title":"Acta Paediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2014.07.022_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.07.022_bb0100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.0013-9580.2004.15904.x","article-title":"Early visual seizures and progressive myoclonus epilepsy in neuronopathic Gaucher disease due to a rare compound heterozygosity (N188S\/S107L)","volume":"45","author":"Filocamo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymgme.2014.07.022_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/humu.20217","article-title":"Gaucher mutation N188S is associated with myoclonic epilepsy","volume":"26","author":"Kowarz","year":"2005","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ymgme.2014.07.022_bb0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ejhg.2013.182","article-title":"Functional analysis of 11 novel GBA alleles","volume":"22","author":"Malini","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2014.07.022_bb0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1005495229655","article-title":"Enzyme replacement therapy in type III Gaucher disease","volume":"22","author":"Tylki-Szyma\u0144ska","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2014.07.022_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0887-8994(87)90033-6","article-title":"Gaucher disease (type III): intellectual profile","volume":"3","author":"Erikson","year":"1987","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2014.07.022_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1010514614570","article-title":"Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease. Management of neuronopathic Gaucher disease: a European consensus","volume":"24","author":"Vellodi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2014.07.022_bb0130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10545-007-0783-8","article-title":"No justification for very high-dose enzyme therapy for patients with type III Gaucher disease","volume":"30","author":"Zimran","year":"2007","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T05:22:39Z","timestamp":1538371359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214002546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1096719214002546"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.022","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}